Milestone Pharmaceuticals is trading at $0.80, up 5.58%, with a 2.32% rise in healthcare offering a possible tailwind; available evidence does not establish the specific cause of the intraday move.
- A Nasdaq notice disclosed October 29 said the share price was below $1.00 for 30 consecutive business days.
- The company has until April 21, 2027, to regain compliance.